PalinGen® XPlus Hydromembrane is a human allograft processed from healthy amniotic tissue exactly like our PalinGen® Hydromembrane but goes through an additional manufacturing step of being chemically cross-linked with glutaraldehyde. The cross-linking of the extracellular matrix fibers gives greater tensile strength, shape manipulation, and slower resorption in vivo. PalinGen® XPlus Hydromembrane is conveniently packaged in sterile saline, to encourage hydration and malleability. It is packaged with sterile, removable mesh on both sides, to ensure it maintains form throughout storage. The mesh is easily removed at the time of insertion.
Amniotic tissue and membrane are known to contain collagen substrates, growth factors and extracellular matrix proteins all recognized as part of the complex wound healing process. Amnio Technology products are derived exclusively from the amnion and are chorion-free. Key natural elements found in placental tissues:
Committed to a culture of Quality and continuous improvement, Amnio Technology has substantially invested in Processing/Manufacturing Operations. Employing state of the art manufacturing clean rooms, as well as closed aseptic isolator technology, ensures Products are processed in a manner that meets and exceeds Quality Standards as well as Regulatory expectations. By way of implementing semi-automated equipment and processes, Amnio Technology has developed a fully validated process which ensures Product Quality and consistency.
Amnio Technology is committed to Compliance, Quality and fosters a culture of Continuous Improvement. Amnio Technology has a core competency in Current Good Tissue Practices (cGTP). Our products meet or exceed the Quality and donor testing expectations set by the FDA in 21 CFR 1271. All Amnio Technology Products are manufactured in an FDA Registered and American Association of Tissue Banks (AATB) accredited facility.
An industry leader in the development and manufacture of amnion-derived technologies
Copyright © 2024 Amnio Technology, LLC